Quillivant XR (methylphenidate HCl) for extended-release oral suspension, 750 mg/150 mL (25mg/5mL...

FDA Drug Recall #D-0608-2017 — Class III — March 7, 2017

Recall Summary

Recall Number D-0608-2017
Classification Class III — Low risk
Date Initiated March 7, 2017
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Pfizer Inc
Location Peapack, NJ
Product Type Drugs
Quantity 11,862 units

Product Description

Quillivant XR (methylphenidate HCl) for extended-release oral suspension, 750 mg/150 mL (25mg/5mL), Rx Only, Distributed by: NextWave Pharmaceuticals, Inc. A subsidiary of Pfizer Inc, New York, NY 10017 Manufactured by: Tris Pharma, Inc., Monmouth Junction, NJ 08852 (NDC 24478-205-25).

Reason for Recall

Failed Dissolution Specifications: Dissolution at 8 hour was out of specification at 12 month at 25 degree Celsius.

Distribution Pattern

Nationwide within US

Lot / Code Information

Lot #: 03216026A, Exp. 02/18

Other Recalls from Pfizer Inc

Recall # Classification Product Date
D-0590-2025 Class II Vial Label: Epinephrine Injection, USP, 1mg/10m... Aug 4, 2025
D-0591-2025 Class II Vial Label: 8.4% Sodium Bicarbonate Injection, ... Aug 4, 2025
D-0607-2017 Class III Quillivant XR (methylphenidate HCl) for extende... Mar 7, 2017
D-0609-2017 Class III Quillivant XR (methylphenidate HCl) for extende... Mar 7, 2017
D-0800-2016 Class III Adult Robitussin PEAK COLD Cough & Chest Conges... Feb 10, 2016

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.